Accès ouvert
2026
article
OpenAlex
Benjamin D. Tyndall, Angela Gasdaska, M. Daniel Brannock, E Preble et autres
BACKGROUND: Growing evidence suggests glucagon-like peptide-1 receptor agonists (GLP-1RAs) may represent a novel potential pharmacotherapeutic tool for alcohol use disorder (AUD). The objective of this study is to examine the association between GLP-1RA prescriptions and alcohol use. METHODS: This cohort study used …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Benjamin Dylan Tyndall, Angela Gasdaska, M. Daniel Brannock, Edward Preble et autres
Abstract Importance Alcohol use is a leading cause of morbidity and mortality worldwide. Growing evidence suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may represent a novel potential pharmacotherapeutic tool for alcohol use disorder (AUD). Objective To examine the association between GLP-1RA prescriptions …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Barrett Wallace Montgomery, Mahmoud Elkasabi, M Daniel Brannock, Laura Marcial et autres
The National Institutes of Health's All of Us Research Program (All of Us) aims to enhance precision medicine by collecting multimodal data from 1 million or more participants. Because All of Us prioritizes enrollment from populations for which there is limited data …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Angela Gasdaska, Benjamin Dylan Tyndall, Edward Preble, M Daniel Brannock et autres
Abstract Importance Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are fast-growing treatments for type 2 diabetes, obesity, and sleep apnea and are under investigation as potential treatments for many other conditions. The National Institutes of Health’s (NIH’s) All of Us Research Program offers a …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Jun Yao Wu, Su-Ji Cho, Katherine D. Descant, Peter H. Li et autres
us, ca
(code pays fourni par la source)